Related Experiment Video
Updated: Jul 13, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Prognostic factors in patients with cerebral sinus venous thrombosis presenting with hemorrhage and papilledema
Ayşegül Şeyma Sarıtaş1, Melike Batum1, Ceyla Ataç2
1Celal Bayar University Neurology Department Manisa, Turkey.
Insights
This study identified key thromboinflammatory markers predicting hemorrhage and papilledema in cerebral sinus vein thrombosis (CSVT) patients. Evaluating these markers aids in assessing CSVT prognosis and risk factors.
Area of Science:
- Neurology
- Hematology
- Immunology
Background:
- Cerebral sinus vein thrombosis (CSVT) pathogenesis and prognosis are linked to thromboinflammation.
- Understanding thromboinflammatory markers is crucial for managing CSVT.
Purpose of the Study:
- To compare thromboinflammatory parameters in CSVT patients versus healthy controls.
- To analyze these parameters in CSVT subgroups based on hemorrhage and papilledema presence.
- To identify predictors of hemorrhage and papilledema in CSVT.
Main Methods:
- Retrospective comparison of thromboinflammatory markers in 88 CSVT patients and 80 controls.
- Analysis of CSVT subgroups: with/without hemorrhage (35/53) and with/without papilledema (52/36).
- Univariate and multivariate analyses to determine risk factors for hemorrhage and papilledema.
Main Results:
- Significant hemorrhage risk factors in CSVT: low hematocrit (<30.2%), low mean platelet volume (≤8.9 fL), high neutrophil count (>5600), and high hsCRP (>9 mg/L).
- Key papilledema risk factors in CSVT: younger age (≤49), vomiting, blurred vision, high HDL (>47 mg/dL), and high D-dimer (>178 ng/mL).
Conclusions:
- Serum thromboinflammatory parameters are critical for predicting CSVT prognosis.
- Demographic characteristics and neurological findings also play a significant role in CSVT risk assessment.
Objective:
The thromboinflammatory process is considered to play a role in the pathogenesis and prognosis of cerebral sinus vein thrombosis (CSVT). The purpose of the study was to compare the thromboinflammatory parameters between individuals with CSVT and healty controls. Additionally, the study sought to compare these parameters among CSVT subgroups with and without haemorrhage, as well as with and without papilledema. Furthermore, the investigation also aimed to identify which parameters had a more significant impact on the risk of hemorrhage and the development of papilledema in CSVT.
Methods:
Thromboinflammatory parameters were compared retrospectively between the CSVT group of 88 patients and 80 age- and sex-matched healthy controls, and in the CSVT subgroups with (n = 35) /without hemorrhage (n = 53) and with (n = 52) /without papilledema (n = 36) after ethics committee approval. In both groups, parameters contributing to the risk of hemorrhage and papilledema development were determined by univariate and multivariate analyses.
Results:
Regarding the risk of hemorrhage in CSVT patients, the most significant factors included hematocrit of <30.2 (%), mean platelet volume of ≤8.9 fL, neutrophil count of >5600, and hsCRP of >9 mg/L. Regarding the risk of papilledema development, the most important risk factors were age of ≤49, presence of vomiting, presence of blurred vision, HDL of >47 mg/dL, and D-dimer of >178 ng/mL.
Conclusion:
It was suggested that evaluating serum thromboinflammatory parameters, as well as demographic characteristics and neurological examination findings, had a critical role regarding prognosis and predictive factors in CSVT.
More Related Videos
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies

